GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Cyclically Adjusted FCF per Share

InNexus Biotechnology (InNexus Biotechnology) Cyclically Adjusted FCF per Share : $0.00 (As of Mar. 2011)


View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

InNexus Biotechnology's adjusted free cash flow per share for the three months ended in Mar. 2011 was $-0.001. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.00 for the trailing ten years ended in Mar. 2011.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-06-22), InNexus Biotechnology's current stock price is $0.0001. InNexus Biotechnology's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2011 was $0.00. InNexus Biotechnology's Cyclically Adjusted Price-to-FCF of today is .


InNexus Biotechnology Cyclically Adjusted FCF per Share Historical Data

The historical data trend for InNexus Biotechnology's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology Cyclically Adjusted FCF per Share Chart

InNexus Biotechnology Annual Data
Trend Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07 Jun08 Jun09 Jun10
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

InNexus Biotechnology Quarterly Data
Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of InNexus Biotechnology's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, InNexus Biotechnology's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InNexus Biotechnology's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InNexus Biotechnology's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where InNexus Biotechnology's Cyclically Adjusted Price-to-FCF falls into.



InNexus Biotechnology Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, InNexus Biotechnology's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2011 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2011 (Change)*Current CPI (Mar. 2011)
=-0.001/94.3376*94.3376
=-0.001

Current CPI (Mar. 2011) = 94.3376.

InNexus Biotechnology Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
200106 -0.005 77.983 -0.006
200109 -0.002 77.904 -0.002
200112 -0.011 76.956 -0.013
200203 -0.024 78.141 -0.029
200206 -0.010 78.931 -0.012
200209 -0.005 79.721 -0.006
200212 -0.002 79.879 -0.002
200303 -0.030 81.459 -0.035
200306 -0.022 80.985 -0.026
200309 -0.014 81.459 -0.016
200312 -0.009 81.538 -0.010
200403 -0.013 82.091 -0.015
200406 -0.029 83.039 -0.033
200409 -0.012 82.960 -0.014
200412 -0.016 83.276 -0.018
200503 -0.012 83.987 -0.013
200506 -0.020 84.461 -0.022
200509 -0.014 85.647 -0.015
200512 -0.020 85.015 -0.022
200603 -0.021 85.805 -0.023
200606 -0.030 86.516 -0.033
200609 -0.022 86.279 -0.024
200612 -0.036 86.437 -0.039
200703 -0.028 87.780 -0.030
200706 0.007 88.412 0.007
200709 -0.034 88.412 -0.036
200712 -0.032 88.491 -0.034
200803 0.014 88.965 0.015
200806 -0.114 91.177 -0.118
200809 -0.027 91.414 -0.028
200812 0.003 89.518 0.003
200903 -0.024 90.071 -0.025
200906 0.009 90.940 0.009
200909 -0.008 90.624 -0.008
200912 -0.006 90.703 -0.006
201003 -0.002 91.335 -0.002
201006 -0.001 91.809 -0.001
201009 -0.001 92.362 -0.001
201012 0.000 92.836 0.000
201103 -0.001 94.338 -0.001

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


InNexus Biotechnology  (GREY:IXSBF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


InNexus Biotechnology Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


InNexus Biotechnology (InNexus Biotechnology) Business Description

Traded in Other Exchanges
N/A
Address
1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7
InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology (InNexus Biotechnology) Headlines

No Headlines